v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
 Net cash provided by (used in): Operating activities      
Net loss for the period $ (1,930,180) $ (1,291,596)
Adjustments to reconcile net loss to net cash used in operating activities:    
Accretion 5,324 4,835
Depreciation 36,385 35,434
Stock-based compensation 454,647 172,415
Non-cash lease expenses 7,629 8,860
Changes in operating assets and liabilities    
Prepaid expenses (1,169,923) 5,023
Other receivables 26,241 (14,540)
Accounts payable 98,171 57,820
Accrued liabilities (58,598) 109,223
Lease liabilities (9,469) (8,811)
Net cash used in operating activities (2,539,773) (921,337)
Investing activities    
Purchase of equipment (236,845)
Net cash used in investing activities (236,845)
Financing activities    
Proceeds from common shares issued upon exercise of warrants 108,329
Net cash provided by financing activities 108,329
Net change in cash, cash equivalents and restricted cash (2,668,289) (921,337)
Cash, cash equivalents and restricted cash, beginning of period 7,420,797 3,967,008
Cash, cash equivalents and restricted cash, end of period $ 4,752,508 $ 3,045,671